Category:

Health

Latest

COVID-19 spurs calls to boost protections for millions of homeworkers

“Homeworkers have been invisible for too long. But the explosion in homeworking during the pandemic has highlighted the poor working conditions experienced by millions worldwide,” ILO economist Janine Berg told the Thomson Reuters Foundation.

Homeworkers earn on average 13% less than non-homeworkers in Britain, 22% less in the United States, 25% less in South Africa and about 50% less in Argentina, India and Mexico, the ILO said in a report.

read more

Ebola vaccines stockpiled against future outbreaks

In a statement, WHO, Doctors Without Borders, UNICEF and the International Federation of Red Cross and Red Crescent Societies said they were establishing an emergency reserve of about 500,000 doses; nearly 7,000 are available now and more will be added throughout the year and beyond. Financial support for the vaccine stockpile was provided by the vaccines alliance GAVI.

read more

Governments should partner with pvt sector to maximise the potential of digital healthcare in Asia:Survey

Social media is the most frequently cited source of personal health and wellness information. However, the survey respondents overwhelmingly agreed that the most trustworthy sources are national government and public health authorities. Governments can seize the opportunity by becoming the most reliable source of quality health information for citizens.

read more

India records 12,584 new cases, lowest in seven months

The number of people who have recuperated from the disease surged to 1,01,11,294 pushing the national COVID-19 recovery rate to 96.49 per cent, while the COVID-19 case fatality rate stands at 1.44 per cent.

The COVID-19 active caseload remained below 3 lakh.

There are 2,16,558 active coronavirus infections in the country which comprises 2.07 per cent of the total caseload, the data stated.

read more

GSK, Vir to test antibody for COVID-19 treatment

The new trial, supported by England’s National Health Service, is expected to begin in the first quarter of 2021 at multiple sites across the UK, the companies said in a joint statement. Preclinical data suggested the companies’ monoclonal antibody (mAb) has the ability to clear infected cells and the potential to enhance virus-specific T cell function, which could help treat and/or prevent infection

read more